ArticleFrontiers in endocrinology2025
High sperm DNA stainability might not be an accurate predictive indicator of male fertility and assisted reproductive technology outcomes.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sperm DNA fragmentation and its impact on pregnancy outcomes: a narrative review focusing on threshold definition and clinical strategies.Translational andrology and urology · 2026Review
- Epidemiology, Etiopathogenesis, Diagnosis, and Treatment of Male Infertility-Current Trends and Future Directions: A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical need for assisted reproduction continued to increase, so did the need for predictive markers of assisted reproductive technology (ART) outcomes. Among all the markers, sperm DNA integrity was paid more and more attention in the assessment of male fertility in recent years, but its clinical value remains still in doubt. Methods: We conducted a retrospective cohort study. Couples coming to our reproductive center were retrospectively enrolled, and semen and assisted reproductive technology parameters were assessed. Sperm DNA integrity was analyzed using a flow cytometric method. Statistics were analyzed to investigate the relationship of this on semen quality and ART outcomes. Results: DNA fragmentation index (DFI) was affected by abstinence days and age, and was a directly correlated with sperm quality parameters (p<0.001). Meanwhile high sperm DNA stainability (HDS) showed an unexplainable negative correlation with abstinence days (p<0.05), age (p<0.001) and body mass index (p<0.01).For sperm quality parameters, HDS showed a similar relevance besides abnormal sperm head morphology (p<0.001). Embryo cleavage and implantation rates were significantly negatively related to DFI in fresh intracytoplasmic sperm injection cycles (p<0.01) while HDS showed a positive relationship with high quality embryo rate (p<0.05). For final outcomes, only the live birth rate from fresh intracytoplasmic sperm injection cycles was positively correlated with DFI which is meaningless (p<0.05). Conclusions: HDS might not be an appropriate marker for male fertility and further studies are needed to identify the efficiency of SDF in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.